JN Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 93: 3146-3156, 2005. First published January 12, 2005; doi:10.1152/jn.00865.2004
0022-3077/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/6/3146    most recent
00865.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denson, D. D.
Right arrow Articles by Eaton, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denson, D. D.
Right arrow Articles by Eaton, D. C.

Activation of BK Channels in GH3 Cells by a c-PLA2-Dependent G-Protein Signaling Pathway

D. D. Denson1,3, J. Li2,3, X. Wang1 and D. C. Eaton2,3

1Departments of Anesthesiology and 2Physiology and 3The Center for Cellular and Molecular Signaling, Emory University School of Medicine, Atlanta, Georgia

Submitted 23 August 2004; accepted in final form 10 January 2005


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
BK-channels in GH3 cells are activated by arachidonic acid produced by c-PLA2. {beta}-adrenergic agonists also activate BK channels and were presumed to do so via production of cAMP. We, however, show for the first time in GH3 cells that a {beta}-adrenergic agonist activates a pertussis-toxin-sensitive G protein that activates c-PLA2. The arachidonic acid produced by c-PLA2 then activates BK channels. We examined BK channels in cell-attached patches and in excised patches from untreated GH3 cells and from GH3 cells exposed to c-PLA2 antisense oligonucleotides. For the cell-attached patch experiments, physiologic pipette and bath solutions were used. For the excised patches, 150 mM KCl was used in both the pipette and bath solutions, and the cytosolic surface contained 1 µM free Ca2+ (buffered with 5 mM K2EGTA). Treatment of GH3 cells with the G protein activator, fluoroaluminate, (AlF4) produced an increase in the Po of BK channels of 177 ± 41% (mean ± SD) in cell-attached patches. Because G proteins are membrane associated, we also added an activator of G proteins, 100 µM GTP-{gamma}-S, to the cytosolic surface of excised patches. This treatment leads to an increase in Po of 50 ± 9%. Similar treatment of excised patches with GDP-{beta}-S had no effect on Po. Isoproterenol (1 µM), an activator of {beta}-adrenergic receptors and, consequently, some G proteins, increased BK channel activity 229 ± 37% in cell-attached patches from cultured GH3 cells. Western blot analysis showed that GH3 cells have {beta}-adrenergic receptor protein and that isoproterenol acts through these receptors because the {beta}-adrenergic receptor antagonist, propanolol, blocks the action of isoproterenol. To test whether G protein activation of BK channels involves c-PLA2, we studied the effects of GTP-{gamma}-S on excised patches and isoproterenol on cell attached patches from GH3 cells previously treated with c-PLA2 antisense oligonucleotides or pharmacological inhibitors of c-PLA2. Neither isoproterenol nor GTP-{gamma}-S had any effect on Po in these patches. Similarly, neither isoproterenol nor GTP-{gamma}-S had any effect on Po in cultured GH3 cells pretreated with pertussis toxin. Isoproterenol also significantly increased the rate of arachidonic production in GH3 cells. These results show that some receptor-linked, pertussis-toxin-sensitive G protein in GH3 cells can activate c-PLA2 to increase the amount of arachidonic acid present and ultimately increase BK-channel activity.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Large-conductance Ca2+-activated potassium (BK) channels are widely distributed in many tissues. Six functionally distinct types of BK channels have been described within the CNS (Reinhart et al. 1989Go). BK channels are intimately associated with such widely diverse CNS functions as neural regulation of the heart originating in the nucleus tractus solitarius and sleep, which is dependent on repetitive rhythmic activity originating in the reticular formation of the thalamus (Golomb et al. 1994Go). BK channels are also involved in neuropeptide secretion, regulation of presynaptic calcium signals, and neurotransmitter release (Robitaille and Charlton 1992Go). Because of the physiological importance of BK channels, we have been particularly interested in the cellular signaling mechanisms responsible for controlling the activity of BK channels. As their name suggests, Ca2+-activated potassium channel activity is altered by intracellular calcium; however, because of their important role in the CNS function, it is not surprising that other signaling pathways also regulate these channels. In previous work, we have demonstrated that the arachidonic acid produced from cytosolic phospholipase A2 increases BK channel open probability in GH3 cells (Denson et al. 1999Go). Until recently it has been thought that optimal activation of c-PLA2 requires both increases in intracellular Ca2+ and phosphorylation (Gijón et al. 1999Go). It was also thought that c-PLA2 resided in the cytosol and translocated to the cell membrane only in response to large increases in intracellular Ca2+ (Clark et al. 1991Go). However, in many cells, including GH3 cells, there is a significant pool of c-PLA2 constitutively associated with the membrane which is capable of producing arachidonic acid (Denson et al. 2001Go; Liu et al. 2001Go; Osterhout and Shuttleworth 2000Go). Whether membrane associated or not, c-PLA2 can be further activated by several mechanisms including phosphorylation by protein kinase C (PKC) or mitogen activated protein kinase (MAPK), by reactive oxygen species like H2O2, by increases in intracellular Ca2+ and by ligand binding to any G-protein-coupled receptor (GPCR) that activates the G protein, Gi or Go. This activation of cPLA2 results in an increased production of arachidonic acid and corresponding increase in the Po of BK channels (Barlow et al. 2000Go; LaBelle and Polyak 1998Go; Leslie 1997Go). Receptor-linked heterotrimeric G proteins have also been reported to activate both BK channels and c-PLA2 (Kruger et al. 1995Go; Tong et al. 1998Go; Yousufzai and Abdel-Latif 1993Go). For example, isoproterenol, a nonselective {beta} adrenergic agonist, activates c-PLA2 via a GPCR (Chung et al. 1999Go; LaBelle and Polyak 1998Go; Nara et al. 1998Go). Although it is clear that G proteins can activate c-PLA2 in some systems, the role of G proteins in BK activation remains unclear. In this paper, we investigated whether heterotrimeric G proteins, endogenous to GH3 cells (Gudermann et al. 1996Go; Paulssen et al. 1992Go), could activate BK-channels in cultured GH3 cells and the mechanism by which this activation occurs.

GH3 cells are a continuous neurosecretory cell line originally derived from the anterior pituitary. They have been used as a neuronal model and a model of cellular secretion (Kushmerick et al. 1999Go). These electrically excitable neurosecretory cells have spontaneous action potentials that are dependent on both K+ and Ca2+ and have a complete GPCR signal transduction cascade linking agonist stimulation by thyrotropin releasing hormone (TRH) to prolactin release (Gershengorn 1986Go). Neurophysiologically, this cell line serves as a cellular model for the study of pituitary autocrine and paracrine function (Vankelecom and Denef 1997Go).

We used GH3 to examine the effect of a {beta}-adrenergic agonist on BK channels using cell-attached patches and then examined the mechanism for activation of the BK channels in excised, inside-out patches. This meant we could examine the effects of G protein activation at constant cytosolic calcium and without complications from other signaling pathways. Based on our experiments, we conclude that isoproterenol activates a pertussis-toxin-sensitive G protein that activates BK channels by activation of cPLA2 and subsequent production of arachidonic acid.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Cell culture

The GH3 cell line was obtained from American Type Culture Collection (ATCC; Rockville, MD) and were grown at 37° in a 5% C02 atmosphere in Dulbecco's minimum essential media (DMEM) supplemented with 15% heat-activated horse serum, 2.5% fetal bovine serum, and 2 mM glutamine. Cells for electrophysiologic experiments were plated on polylysine-coated petri dishes to which a polycarbonate recording chamber with a volume of 0.2 ml had been previously affixed with silicone elastomer (Sylgard). Cells were used 1–3 days after plating, and cells from passages 25–45 were used in the experiments described in this manuscript. Previous studies have demonstrated a consistent Po versus [Cai2+] and Po versus mV relationship as well as the extent of BK-channel expression exists over this range of cell passages (Denson et al. 1996Go, 1999Go, 2001Go).

c-PLA2 sense and antisense oligonucleotides

Sense and antisense oligonucleotides targeting two possible translation start codons of rat c-PLA2 were synthesized by the Microchemical Facility of Emory University (Atlanta, GA) as previously described (Denson et al. 1999Go, 2001Go). We have previously reported that treatment of cultured GH3 cells with 5 µM of each antisense oligonucleotide in serum-free media for 20–24 h results in ca 80% decrease in c-PLA2 by both Western blot and direct biochemical assay (Denson et al. 1999Go).

Drug exposure paradigm

For all experiments, drug exposure was effected using a gravity perfusion/suction removal technique with a perfusion rate of 2.0 ml/min and a dead volume of 1.0 ml. Previous experiments showed that exchange was 90 ± 7% complete after 0.5 min (Denson and Eaton 1994Go). After obtaining a high resistance (>25 G{Omega}) seal, patches were excised in a 1 µM Cai2+ solution. Control recordings were obtained in K2EGTA-buffered solutions containing the desired Cai2+ concentration as described in the following text.

Electrophysiologic recordings

All experiments in this study used either the cell-attached or the excised (inside-out) patch configuration of the patch-clamp technique. Electrodes were fabricated from Corning 7052 glass (Garner Glass, Fullerton, CA) in two steps on a Narishige PP-83 electrode puller (Narishige, Tokyo, Japan). Electrodes were fire polished to a final tip resistance between 3 and 5 M{Omega}. Recordings were performed at room temperature with a Dagan Model 3900 patch-clamp amplifier (Dagan, Minneapolis, MN). All experiments were conducted with the patch depolarized to +20 mV. Single-channel data were digitized using Axoscope-7 software (Axon Instruments; Foster City, CA) at a sampling rate of 5 kHz and filtered at 2 kHz using a 4-pole low-pass Bessel filter.

Data analysis

The digitized single-channel data were analyzed in 1-min segments to generate NPo versus time plots using Fetchan and P-Stat software programs (Axon Instruments). NPo versus time plots were used to determine the time course for reaching a stable maximum effect for each series of experiments. Open probabilities were determined from the amplitude histograms by fitting each amplitude histogram to the appropriate sum of Gaussian distribution functions using iterative nonlinear regression software (PeakFit 4; SPSS, Chicago, IL) after correction of the baseline to make 0 current coincident with the state in which all channels were closed. NPo values were first calculated from the amplitude histogram. The open probability (Po) was then calculated as NPo/N. The number of channels in each patch (N) was estimated by dividing the total conductance obtained during exposure of the patch to 100 µM Cai2+ by the unit conductance associated with a one-state change. Because the duration of open and closed intervals varied from very short to very long durations, data obtained from a patch, which contained a single channel, were binned logarithmically and analyzed according to the method of Sigworth and Sine (1987)Go.

Solutions

The solutions used in all patch-clamp experiments were (in mM) 150 KCl, 2 MgCl2, and 10 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), pH 7.30, or 140 KCl, 5 HEPES, 5 K2EGTA, and 4.55 CaCl2 (10 µM free ionized Ca2+), pH 7.30, for the pipette and 140 KCl, 15 HEPES, 5 K2EGTA, and 0.1, 1, or 100 µM Cai2+ pH 7.4 for the bath. AlF4 solutions were prepared immediately before use by adding AlCl3 and NaF to the standard bath solution as previously described (Susa et al. 1997Go). Solutions of GTP-{gamma}-S, GDP-{beta}-S, pertussis toxin (PTX), and isoproterenol were all prepared at the desired concentration in bath solution immediately prior to use.

Drugs and chemicals

c-PLA2 sense and antisense oligonucleotides (described in the preceding text) were synthesized by the Microchemical Facility of Emory University (Atlanta, GA). GTP-{gamma}-S, GDP-{beta}-S, pertussis toxin (PTX), and isoproterenol were all obtained from Sigma-Aldrich, St. Louis, MO. The c-PLA2 inhibitor, arachidonyl trifluoromethyl ketone (AACOCF3) was obtained from Biomol (Plymouth Meeting, PA). A polyclonal antibody (host:rabbit) for the {beta}1-receptor was obtained from Novus Biologicals (Littleton, CO). A polyclonal antibody (host:chicken) for the {beta}2-receptor was obtained from Chemicon International (Temecula, CA). Corresponding secondary antibodies were obtained from KPL (Gaithersburg, Maryland) and Chemicon International.

Arachidonic acid efflux protocol

The efflux of labeled arachidonic acid from cells in response to agonists has been used as a measure of cellular production of arachidonic acid in GH3 cells (Denson et al. 1996Go). Efflux experiments were conducted as previously reported. Briefly, sufficient 3H-arachidonic acid in ethanol to result in a final concentration of 1 µCi/ml media was evaporated to dryness under dry nitrogen, serum-free GH3 media containing 0.2% BSA added, and the mixture vortexed. GH3 cells plated at a density of 1 x 106 cells/dish in a six-well plate were incubated in 2 ml GH3 media containing labeled arachidonic acid. After an overnight exposure, sample was counted and the remaining "hot" media was carefully removed. The cells were then washed three times with 2 ml arachidonic-acid-free media and returned to the incubator. At each time point of interest, sample of the media was removed and counted and the sample volume replenished with fresh arachidonic-acid-free media. Following the last sample, media was removed and 1 N NaOH was added to lyse the cells. After 2 min, 1 N HC1 was added to neutralize the NaOH. The cells were scraped and vortexed, and a sample was removed for counting the remaining radioactivity in the cells. Rates of arachidonic acid release were calculated at each time point from the fraction of total counts remaining at the corresponding time.

Western blot analysis

Western blot analysis was completed as previously described (Denson et al. 1999Go). Briefly, ~107 GH3 cells were grown in a T-75 tissue culture flask. Media was removed, the cells washed with PBS and scraped in fresh PBS and centrifuged at 4°C. The pellet was resuspended in 300 µl of RIPA buffer (150 mM NaCl, 10 mM NaPO4, pH 7.2, 1% NP-40, 0.1% SDS, and 0.25% deoxycholate) containing protease inhibitors (antipan, leupeptin, pmsf, tpck/tlck). After cell lysis (1 h at 4°C), the suspension was centrifuged at 2000 g for 10 min to precipitate unlysed cells. Samples were prepared for SDS-polyacrylamide gel electrophoresis by diluting the supernatant with sample buffer (Tris, pH 6.8; 0.1%SDS, 10% glycerol, and 0.025% Bromphenol Blue) and heating at 95°C for 10 min. The resultant solution (45 µl) was loaded in each lane on a 7.5% polyacrylamide gel. After electrophoresis (~1 h at 150 V), the proteins were transferred to nitrocellulose. The nitrocellulose blots were then probed with primary antibodies for either the {beta}1- or {beta}2-adrenergic receptor. For detection of the {beta}1-receptor, a rabbit polyclonal antibody at a dilution of 1:500 was used. For detection of the {beta}2-receptor, a chicken polyclonal antibody at a dilution of 1:500 was used. Blots were then washed and incubated with a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:10,000) for 1 h at room temperature for the {beta}1-receptor or a goat anti-chicken antibody (1:5000) for the {beta}2-receptor. Receptors were visualized by chemiluminescence using an ECL kit from Sigma (EPS-1, Sigma-Aldrich). The {beta}1-receptor was assigned to the band at ~64 kDa, whereas the {beta}2-receptor was assigned to a band between 50 and 75 kDa.

Statistical analysis

Within group comparisons for two treatments were accomplished using a t-test for repeated measures. In all cases, a P value of <0.05 was required to reject the null hypothesis. Intergroup comparisons for a single treatment were made using an ANOVA followed either by a post hoc Scheffe or Tukey test for multiple comparisons as appropriate. All data are presented as means ± SD unless otherwise specified.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Single BK-channel characteristics

Single BK channel currents were recorded with two patch-clamp configurations: cell attached patches to measure the effects of the nonselective {beta}-adrenergic agonist, isoproterenol, and the G protein activator, AlF4. Excised, inside-out patches were used for all other measurements. Unit conductance for all channels regardless of configuration was 288 ± 13 pS. However, as might be expected, there was a large difference in the open probability (Po) between channels recorded with the two different patch-clamp configurations (cell attached and excised inside-out). The cell-attached configuration, in the absence of a calcium ionophore, results in a much lower Po than an excised patch. In addition, groups of cells treated with antisense oligonucleotides directed against c-PLA2 have inherently lower Po values for either configurations when compared with their untreated counterparts. Despite these differences in Po between different treatment groups, the within-group variability is consistently small (ca 30%) for each experimental condition studied. The two intracellular Ca2+ concentrations of 0.1 and 1 µM were chosen because this is the normal range encountered before, during, and after an action potential in GH3 cells (Schlegel et al. 1987Go).

Both fluoroaluminate (AlF4) and GTP-{gamma}-S increase BK-channel activity in cultured GH3 cells

Cell-attached patches were used for experiments with the G protein activator, AlF4. AlF4 is quite membrane permeable so that G protein activation by external application of AlF4 is almost as rapid and complete as is application to the cytosolic surface of excised patches (Susa et al. 1997Go; Yousufzai and Abdel-Latif 1993Go). After we made control recordings of BK-channel activity with the patch depolarized to +20 mV, a freshly prepared solution of 10 µM AlF4 was added, and BK-channel activity was recorded continuously for 10 min. Treatment of cultured GH3 cells with extracellular AlF4 resulted in a highly significant increase (P < 0.001) in BK-channel activity (177 ± 41%; n = 8, mean ± SD) and was significantly greater (P < 0.01) than the increase with GTP-{gamma}-S. This may be due to the fact that GTP-{gamma}-S is hydrolyzed, albeit slowly, whereas AlF4 binds to and locks the G protein into a persistently activated state. Treatment of excised patches from GH3 cells, depolarized to +20 mV and exposed to 0.1 µM intracellular Ca2+, with 100 µM GTP-{gamma}-S also resulted in a consistent and significant (P < 0.001) increase in BK-channel activity of 50 ± 9% (n = 8; see Fig. 1). There was no significant change in the voltage dependence of Po over the range of 0 to +60 mV after GTP-{gamma}-S treatment (data not shown).



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 1. Activation of G proteins results in BK-channel activation in cultured GH3 cells. A: a comparison of BK-channel activity in untreated cell-attached patches and patches treated with 0.5 mM AlF4. B: untreated excised patches and excised patches treated with 100 µM GTP-{gamma}-S. All experiments were conducted with VH = +20 mV. Solutions used in these experiments are described in METHODS. For the single-channel records in this figure, the ‘C’ represents level when all channels are closed. The numerical values (e.g., 1, 2,...) represent the number of channels open. A illustrates a representative experiment with AlF4. The unit conductance of the channels in this patch is 235 pS. AlF4 resulted in an increase in Po from 0.09 (untreated cells; top) to 0.19 (cells treated with AlF4, bottom). B illustrates a representative experiment with GTP-{gamma}-S with a [Cai2+] of 0.1 µM. The unit conductance of the channels in this patch is 345 pS. GTP-{gamma}-S resulted in an increase in Po from 0.22 (untreated cells; top) to 0.35 (cells treated with GTP-{gamma}-S; bottom). C and D provide a summary of these experiments. C: treatment of cultured GH3 cells with AlF4, resulted in a highly significant increase (P < 0.001) in BK-channel activity of 177 ± 41% (n = 8, mean ± SD) and was significantly greater (*P < 0.01) than the increase with GTP-{gamma}-S. D: treatment of excised patches from cultured GH3 cells, with 100 µM GTP-{gamma}-S also resulted in a consistent and significant (P < 0.001) increase in BK-channel activity of 50 ± 9% (n = 8).

 
Isoproterenol activates BK channels in GH3 cells

The effect of AlF4 and GTP-{gamma}-S suggested that activation of G proteins could activate BK channels. Therefore we examined the effect of isoproterenol, an agonist for one type of GPCR, {beta}-adrenergic receptors. We chose isoproterenol because it stimulates the release of growth hormone in GH3 cells (Gabriel et al. 1989Go). Because BK channels also regulate the release of growth hormone in GH3 cells, we sought to determine whether treatment of GH3 cells with isoproterenol would result in BK-channel activation. We used cell-attached patches depolarized to +20 mV. After control recordings had been made, we added 1 µM isoproterenol to the bath and recorded single-channel activity continuously for an additional 10 min. The Po of channels in the cell-attached patches was relatively low presumably because of low intracellular calcium; nonetheless, treatment of GH3 cells with isoproterenol resulted in a significant increase in BK-channel activity (P < 0.001). Po increased from 0.029 ± 0.010 in control patches to 0.092 ± 0.030 after treatment with isoproterenol (see Fig. 2, A and C). The effects of isoproterenol could be reversed by perfusing the cells with control bath solution without isoproterenol (data not shown).



View larger version (31K):
[in this window]
[in a new window]
 
FIG. 2. One G protein coupled receptor ligand, isoproterenol, activates BK-channels in GH3 cells. A: single-channel recordings were made using the cell-attached patch configuration with a bath [Ca2+] of 2 mM and a VH of +20 mV. After control recordings were made in untreated cells (top 2 traces), a solution containing 1 µM isoproterenol was introduced and the single-channel activity continuously recorded for 10 min (bottom 2 traces). Isoproterenol (1 µM), increased BK-channel activity in this patch from a Po of 0.015 to a Po of 0.039. The unit conductance for the channels in this patch was 216 pS. For the single-channel records in this figure, the C represents the state in which all channels are closed. The numerical values (e.g., 1, 2,...) represent the number of channels in an open state. B, inset: Western blot demonstrating the presence of both {beta}1- and {beta}2-adrenergic receptors in untreated GH3 cells. C: for these experiments, the cell-attached configuration was used with a bath [Ca2+] of 2 mM and a VH of +20 mV. After control recordings were made in untreated cells, a solution containing 1 µM isoproterenol was introduced and the single-channel activity continuously recorded for 10 min. Isoproterenol treatment resulted in a highly significant increase in Po (P < 0.001 by paired t-test) from 0.029 ± 0.004 in control patches to 0.092 ± 0.015 (n = 6). D: for these experiments, the cell-attached configuration was used with a bath [Ca2+] of 2 mM and a VH of +20 mV. After control recordings were made in cells pretreated with 20 µM propranolol, a solution containing propranolol and 1 µM isoproterenol was introduced and the single-channel activity continuously recorded for 10 min. Isoproterenol treatment did not result in a significant increase in Po (P < 0.06 by paired t-test) from 0.037 ± 0.027 in control patches to 0.022 ± 0.011 (n = 8).

 
There have been differing reports in the literature of whether GH3 cells endogenously express {beta} adrenergic receptors (Gabriel et al. 1989Go; Guerrero and Minneman 1999Go). Despite our observation of a clear effect of an agonist that is considered to be specific for {beta} adrenergic receptors, we also determined whether we could detect {beta} adrenergic receptors in Western blots of cell lysates obtained from untreated GH3 cells. These experiments unequivocally demonstrated the presence of both the {beta}1 and the {beta}2 receptors (see Fig. 2B).

Isoproterenol activates BK channels via {beta}-adrenergic receptors

Although isoproterenol is generally considered a specific agonist for {beta}-adrenergic receptors (Hoffman 2001Go) that is incapable of activating {alpha}-adrenergic receptors and we had demonstrated the presence of both {beta}1- and {beta}2-adrenergic receptor protein, we also demonstrated that a specific {beta}-adrenergic antagonist (Hoffman 2001Go) blocked the action of isoproterenol on BK channels. For these experiments, we pretreated GH3 cells 20 µM propranolol (Chen et al. 2002Go) for 15 min and then formed a cell-attached patch. Single-channel activity was recorded for 10 min after which the bath solution was replaced with one containing 20 µM propranolol and 1 µM isoproterenol, and BK-channel activity was recorded for an additional 10 min. The VH, bath and electrode solutions were identical to those described above (Fig. 2, A and C) in which the effect of isoproterenol was examined. Propranolol completely eliminated any stimulatory effect of isoproterenol (Fig. 2D). The mean Po in the presence of propranolol alone was 0.037 ± 0.021, whereas the Po for cells treated with propranolol and isoproterenol together was 0.022 ± 0.011, not significantly different from propranolol alone (by 2-tailed t-test for repeated measures: P < 0.06, n = 8). These data further support the idea that the effect of isoproterenol is mediated through {beta}-adrenergic receptors.

Isoproterenol activates BK channels via a pertussis-toxin-sensitive G protein

Although {beta}-adrenergic receptors are traditionally thought to couple to Gs proteins, there are several recent reports of the receptors coupling to Gi (Gosmanov et al. 2002Go; Gudermann et al. 1996Go, 1997Go; LaBelle and Polyak 1998Go; Wellner-Kienitz et al. 2001Go; Xiao 2001Go). Chung et al. (1999)Go reported that isoproterenol could activate BK-channels via a Gi-mediated pathway in rabbit mesenteric arterial smooth muscle cells. Which G protein is involved (Gs or Gi/o) in {beta}-adrenergic-mediated stimulation of BK channels can be determined by treatment with pertussis toxin (PTX); PTX only blocks the Gi/Go family of G proteins and has no effect on Gs activation. Therefore we pretreated GH3 cells with 5 µg/ml PTX for 3 h. PTX completely eliminated the stimulatory effect of isoproterenol on BK-channels (see Fig. 3A). Po in control cells in these experiments was 0.028 ± 0.011, and in cells pretreated with PTX, Po was 0.028 ± 0.014. Although both Gi and Go proteins are present in GH3 cells (Paulssen et al. 1992Go), Chung et al. (1999)Go have shown that only Gi appears to be coupled to the isoproterenol receptor in native cells; therefore the PTX inhibition of the {beta}-adrenergic response is most consistent with inhibition of Gi.



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 3. Isoproterenol activates BK-channels in GH3 cells via a PTX-sensitive G protein receptor coupled to c-PLA2. A: all experiments were conducted using the cell-attached patch configuration with a bath [Ca2+] of 2 mM and the patches depolarized to +20 mV. Po in cells pretreated with PTX (5 µg/ml) for 3 h was 0.028 ± 0.011, and after treatment with isoproterenol, the Po was 0.028 ± 0.014 (P < 0.5; n = 6). The effect of isoproterenol on BK channels in cultured GH3 cells was also inhibited by pretreating cells with c-PLA2 antisense oligonucleotides. Po for control cells in these experiments was 0.011 ± 0.005 and was unchanged after isoproterenol (0.011 ± 0.005; n = 6).

 
Isoproterenol activation of BK channels also requires c-PLA2

In other types of cells, isoproterenol has been reported to activate c-PLA2 via a GPRC mechanism involving Gi (LaBelle and Polyak 1998Go). We have shown in several previous publications that the expression of cPLA2 can be strongly inhibited by treatment with specific antisense oligonucleotides. We used this approach again to show that the effect of isoproterenol on BK channels was also inhibited by pretreating cells with c-PLA2 antisense oligonucleotides. Po for control cells in these experiments was 0.011 ± 0.005 and was unchanged after isoproterenol (0.011 ± 0.005; see Fig. 3B). These data provide additional support for our hypothesis that activation of c-PLA2 (with a corresponding increase in BK-channel activity) can arise via a GPRC mechanism involving Gi/o.

Isoproterenol increases c-PLA2-mediated arachidonic acid release from GH3 cells

We have previously reported that there is tonic c-PLA2-dependent arachidonic acid release in GH3 cells and that compounds that either inhibit or stimulate c-PLA2 result in a corresponding change in arachidonic acid production (Denson et al. 1996Go). To verify our hypothesis that the increase in BK-channel activity observed with isoproterenol treatment was through stimulation of c-PLA2, we studied the effect of isoproterenol on arachidonic acid efflux. Treatment of GH3 cells with 1 µM isoproterenol resulted in a highly significant increase in the rate of arachidonic acid release when compared with control. Specifically, the tonic rate of arachidonic acid release was 0.032 ± 0.016 h–1 (n = 4) and was 0.074 ± 0.009 h–1 (n = 4) after isoproterenol (P < 0.005; see Fig. 4).



View larger version (19K):
[in this window]
[in a new window]
 
FIG. 4. Isoproterenol increases c-PLA2 mediated arachidonic acid release from GH3 cells. For these experiments, GH3 cells were treated with either control media or media containing 1 µM isoproterenol. Samples were withdrawn a 2, 4, 8, 12, 20, and 30 min and at 1, 2, and 3 h for determination of the rate of arachidonic acid efflux as described in the preceding text. Each point in A is the means ± SE for 4 replicates. Isoproterenol ({circ}) resulted in a significant stimulation of arachidonic acid efflux when compared with control ({bullet}; P < 0.005). B: the mean rate of arachidonic acid efflux (as the fraction of total arachidonic acid counts released per hour). Isoproterenol produces a significant increase in efflux (means ± SE for 4 experiments).

 
There is no tonic G protein effect on BK-channel activity

Our previous work has shown that there is significant cPLA2 production of arachidonic acid at normal intracellular calcium concentrations but that this activity can be substantially enhanced by increases in the calcium concentration of the bath bathing the cytosolic surface of excised patches. The tonic activity could either be due to calcium or some other tonically active signaling pathway. If there was tonic activity of Gi/o protein, then inhibition should reduce BK-channel activity. Therefore we compared the effect of the G protein activator, GTP-{gamma}-S, with the G protein inhibitor, GDP-{beta}-S. For this series of comparative experiments, we used excised patches from GH3 cells depolarized to +20 mV and exposed to 1 µM intracellular Ca2+. As expected from the results in Fig. 1B, treatment of cultured GH3 cells with 100 µM GTP-{gamma}-S resulted in an increase in BK-channel activity from a control Po of 0.40 ± 0.04 to 0.60 ± 0.11 (n = 8) within 10 min (Fig. 5A). On the other hand, treatment of cultured GH3 cells with 100 µM GDP-{beta}-S had no significant (P < 0.5) effect on BK-channel activity (n = 6). For this series of experiments, the control Po was 0.47 ± 0.05, whereas the Po after 10 min of treatment with GDP-{beta}-S was 0.45 ± 0.045. (see Fig. 5B).



View larger version (14K):
[in this window]
[in a new window]
 
FIG. 5. Inactivation of G-proteins does not reduce BK-channel activity. For this series of comparative experiments, excised patches from cultured GH3 cells with the patch depolarized to +20 mV and exposed to 1 µM [Cai2+] were used. As noted previously, treatment of cultured GH3 cells with 100 µM GTP-{gamma}-S resulted in an increase in BK-channel activity from a control Po of 0.40 ± 0.04 to 0.60 ± 0.11 (n = 8) within 10 min (A). On the other hand, treatment of cultured GH3 cells with 100 µM GDP-{beta}-S had no significant (P < 0.5) effect on BK-channel activity (n = 6). For this series of experiments, the control Po was 0.47 ± 0.05, whereas the Po after 10 min of treatment with GDP-{beta}-S was 0.45 ± 0.045 (B).

 
G protein activation of BK channels by GTP-{gamma}-S requires c-PLA2

We had already shown that inhibiting expression of cPLA2 could block the effect of isoproterenol. We presumed that this result meant that a G protein activated by the {beta} adrenergic receptor (Gi/o) required cPLA2 activation. To test the hypothesis that the increase in activity observed with GTP-{gamma}-S involved a G-protein signaling pathway in which c-PLA2 was an important component, we exposed excised patches from GH3 cells, which had been pretreated with antisense oligonucleotides against c-PLA2 to 100 µM GTP-{gamma}-S. All excised patches in this set of experiments were exposed to 1 µM intracellular Ca2+ and depolarized to +20 mV. Unlike cultured cells in which the Po of BK channels increased significantly after treatment with GTP-{gamma}-S, Po in patches from antisense-treated cells did not change significantly (0.18 ± 0.02 vs. 0.17 ± 0.03; P < 0.5; see Fig. 6A). Although we and others (Denson et al. 2001Go; Liu et al. 2001Go; Osterhout and Shuttleworth 2000Go) have previously reported that a significant portion of the c-PLA2 pool in GH3 cells normally resides at or near the plasma membrane, we sought to further validate this observation by conducting experiments with the c-PLA2 inhibitorAACOCF3 (Street et al. 1993Go) in excised patches. All excised patches in this set of experiments were exposed to 1 µM intracellular Ca2+ and depolarized to +20 mV. After we obtained control recordings, the patches were exposed to a bath solution containing 15 µM AACOCF3 after which channel activity was continuously recorded for 10 min to ensure any effect of the inhibitor had stabilized. The patches were then exposed to a bath solution containing 15 µM AACOCF3 and 100 µM GTP-{gamma}-S. Channel activity was continuously recorded for an additional 10 min. Like pretreatment with c-PLA2 antisense, addition of AACOCF3 by itself to excised patches resulted in a significant reduction in Po from 0.37 ± 0.08 to 0.21 ± 0.04 (P < 0.001; n = 6). Further addition of GTP-{gamma}-S after AACOCF3 did not result in a significant change in Po (0.21 ± 0.04 vs. 0.20 ± 0.06; P < 0.3; n = 6; see Fig. 6B). These results are essentially identical to those obtained using GH3 cells exposed to antisense oligonucleotides (Fig. 6A) and further demonstrate that a significant amount of active c-PLA2 is available in excised patches in untreated GH3 cells.



View larger version (13K):
[in this window]
[in a new window]
 
FIG. 6. G protein activation of BK-channels by GTP-{gamma}-S requires c-PLA2. A: these experiments utilized excised patches from GH3 cells, which had been pretreated with antisense oligonucleotides against c-PLA2. All excised patches were exposed to 1 µM [Cai2+] and depolarized to +20 mV. After control recordings were completed, patches were exposed to a bath solution containing 100 µM GTP-{gamma}-S. Po in patches from antisense-treated cells did not change significantly (0.18 ± 0.02 vs. 0.17 ± 0.03; n = 6; P < 0.5) after treatment with GTP-{gamma}-S. B: these experiments utilized excised patches from GH3 cells that had been treated with the c-PLA2 inhibitor, AACOCF3 All excised patches were exposed to 1 µM [Cai2+] and depolarized to +20 mV. After control recordings were completed, patches were exposed to a bath solution containing 15 µM AACOCF3. Po in patches from AACOCF3-treated cells decreased significantly (0.37 ± 0.08 vs. 0.21 ± 0.04; P < 0.001; n = 6). After the effect of AACOCF3 had stabilized, patches were exposed to a solution containing 15 µM AACOCF3 and 100 µM GTP-{gamma}-S. Continuous single-channel recordings were made for 10 min. Treatment of the patches with GTP-{gamma}-S did not result in any significant change in Po (0.21 ± 0.04 vs. 0.20 ± 0.06; P < 0.5; n = 6).

 
GTP-{gamma}-S activation of BK channels involves Gi/o

Although PTX blocks the action of isoproterenol implying an involvement of Gi/o protein, GTP-{gamma}-S could activate any G protein available on the cytosolic surface of excised patches. To determine whether Gi/o was the G protein, which activates c-PLA2 in excised patches, we conducted a series of experiments using excised patches from cells that had been pretreated for 3 h with 5 µg/ml PTX. PTX ADP-ribosylates members of the Gi/o family of G proteins. In so doing, PTX prevents receptor-G protein interaction. In addition, pretreatment with PTX also prevents binding and activation of Gi/o by GTP-{gamma}-S or GTP (Katada et al. 1984Go; O'Neill et al. 1990Go; Sariban-Sohraby et al. 1999Go; Xiao et al. 1999Go; Yassin et al. 1996Go). Excised patches from these cells were exposed to a bath solution containing 5 µg/ml PTX and 1 µM intracellular Ca2+. All patches were depolarized to +20 mV. After control recordings were obtained, GTP-{gamma}-S (100 µM) was added to the cytosolic bath and single-channel activity was continuously recorded for an additional ten minutes. Pretreatment of cells with 5 µg/ml PTX completely inhibited the stimulatory effect of GTP-{gamma}-S in cultured GH3 cells. Po for the control cells was 0.38 ± 0.05 and 0.41 ± 0.05 after treatment with GTP-{gamma}-S. These results suggest that Gi/o is the G protein coupled to c-PLA2.

All of the signaling elements required for BK-channel activation by isoproterenol are contained in excised patches

If our hypothesis that isoproterenol binding to {beta}-adrenergic receptors activates c-PLA2 and subsequently BK channels via a Gi/o-dependent pathway, then it should be possible to stimulate BK channels in excised patches by incorporating isoproterenol in the pipette solution (see schematic in Fig. 8B). For these experiments, the bath (intracellular) solution contained 0.1 µM Ca2+ and the patches were depolarized to +20 mV. The tips of the pipettes were filled with saline containing no isoproterenol, and the remainder of the pipette was backfilled with the saline that contained 1 µM isoproterenol. We have previously shown that low-molecular-weight solutes (like isoproterenol will equilibrate with the end of the pipette in 7–10 min. Channel activity was continuously recorded for ~15 min. Repeated measures analysis on data from seven excised patches showed a statistically significant increase in Po from the first 5 min compared with the last 5 (from 0.31 ± 0.06 to 0.38 ± 0.08, P < 0.013; n = 7; see Fig. 7). Interestingly, 4/7 patches increased 28 ± 3%, 2/7 patches increased 8 ± 2% and 1/7 decreased 5%. The activity of untreated patches or patches with no response (compare the effect of GDP-{beta}-S) generally decrease with time. It is statistically unlikely (P = 0.011, z test) in a group of seven patches, that six should increase Po and that four should increase by >25%. These data suggest that all of the transduction elements shown in Fig. 8B are present in many (4/7) if not most (6/7) excised patches from GH3 cells.



View larger version (30K):
[in this window]
[in a new window]
 
FIG. 8. Schematic model of G protein activation of BK channels. This diagram shows the cellular signaling pathways involved in BK channel activation in a cell-attached patch (left) or and excised, inside-out patch (right). On the left, isoproterenol activates {beta}-adrenergic receptors that activate the G protein, Gi/o. Pertussis toxin can block the activation of Gi/o. Activation of Gi/o stimulates cPLA2 to produce arachidonic acid (AA) that has been previously shown to activate BK channels and lysophospholipids (not shown) that could also contribute to the activation. Antisense oligonucleotides that inhibit expression of cPLA2 that inhibit expression of cPLA2 block the action of isoproterenol. Activation of {beta}-adrenergic receptors may also activate other signaling pathway, in particular, increased intracellular calcium. An increase in intracellular calcium would strongly reinforce the stimulation by Gi/o and cPLA2. On the other hand, in excised patches, calcium is held constant and therefore cannot contribute to the activation of BK channels. However, direct stimulation of Gi/o with GTP-{gamma}-S stimulates the channels, an effect that is completely blocked by pertussis toxin. Pretreatment of cells with antisense oligonucleotides against c-PLA2 also completely inhibited the activation of BK channels precluding any direct effect of GTP-{gamma}-S on the channels.

 


View larger version (10K):
[in this window]
[in a new window]
 
FIG. 7. All of the signaling elements required for BK-channel activation by isoproterenol are contained in excised patches. For these experiments, the bath (intracellular) solution contained 0.1 µM Ca2+, and the patches were depolarized to +20 mV. The tips of the pipettes were filled with saline containing no isoproterenol, whereas the remainder of the pipette was backfilled with the saline that contained 1 µM isoproterenol. We have previously shown that low molecular weight solutes (like isoproterenol) will equilibrate with the end of the pipette in 7–10 min. Channel activity was continuously recorded for 15 min. Repeated-measures analysis on data from 7 excised patches showed a statistically significant increase in Po from the 1st 5 min compared with the last 5 (from 0.31 ± 0.06 to 0.38 ± 0.08, P = 0.013; n = 7).

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
BK channels are intimately associated with widely diverse CNS functions. BK channels are extremely important in the control of neuronal excitability. In excitable cells, BK channels work in concert with voltage-activated Ca2+ channels to shape the action potential, determine its duration, and help regulate the frequency of spontaneous action potentials. BK channels activate in response to elevations in intracellular Ca2+ and participate in limiting Ca2+ influx. BK channels are also involved in neuropeptide secretion, regulation of presynaptic calcium signals, and neurotransmitter release (Robitaille and Charlton 1992Go). Because BK channels play such a physiologically important role in CNS function, it is not surprising that there are multiple signaling mechanisms for regulating their activity. We have previously reported that the c-PLA2–arachidonic acid cascade is an important signal transduction pathway for the regulation of BK channels (Denson et al. 1999Go, 2001Go). Barlow et al. (2000)Go have also shown that activation of c-PLA2 by H2O2 resulted in an increase in arachidonic acid production and concomitant increase in BK-channel activity in coronary artery smooth muscle cells. Unlike our findings that BK channel activation was a result of arachidonic acid itself, Barlow et al. suggested the activation in coronary artery smooth muscle was due to a lipoxygenase metabolite of arachidonic acid (Barlow et al. 2000Go; Denson et al. 1999Go). However, they only examined the effect of stimulating c-PLA2 for long periods of time under whole cell conditions. Therefore their results are not comparable to ours. Indeed, because we would expect {beta}-adrenergic receptors to desensitize and be internalized, we do not believe isoproterenol could stimulate c-PLA2 for long enough periods to allow significant production of lipoxygenase products. Moreover, our demonstration of an isoproterenol effect in an excised patch also seems to make the hypothesis of arachidonic acid metabolism unnecessary. However, strictly speaking, we cannot rule out the possibility that, at much longer times after application of {beta}-adrenergic agonists, there may be some contribution of arachidonic acid metabolites in intact cells. On the other hand, besides arachidonic acid, the action of cPLA2 on phospholipids also produces lysophospholipids. It is possible that lysophospholipids could also activate BK channels although there are no examples of such an effect that we can find in the literature. The significance of the present research is the demonstration that, in addition to the well-established contributions of phosphorylation and increases in intracellular Ca2+, a membrane receptor coupled heterotrimeric G protein can also modulate BK channels by the activation c-PLA2. Specifically, our results demonstrate that isoproterenol increases BK-channel activity in GH3 cells; isoproterenol acts through a pertussis-toxin-sensitive G protein, probably Gi or Go; Gi/o-mediated activation of BK channels requires c-PLA2; Isoproterenol treatment results in a significant increase in arachidonic acid production; and isoproterenol and G protein activation of BK channels can occur in excised, inside-out patches precluding the involvement of intracellular calcium and other signaling pathways.

GH3 cells contain {beta}-adrenergic receptors

Although there is one anecdotal report suggesting no endogenous expression of adrenergic receptors in GH3 cells (Guerrero and Minneman 1999Go), others have shown that isoproterenol can stimulate growth hormone release in GH3 cells through both {beta}1- and {beta}2-receptors (Gabriel et al. 1989Go). In the present investigation, Western blot analysis of cell lysates from untreated GH3 cells revealed easily detectable amounts of both the {beta}1- and {beta}2-adrenergic receptors, further demonstrating our data are consistent with this observation.

Model for G protein activation of BK channels in GH3 cells

Figure 8 shows a schematic drawing of the mechanism for G protein activation of BK channels. In this model in cell-attached patches (A), isoproterenol activates {beta}-adrenergic receptors that activate the G protein, Gi/o (as others have recently described (Gosmanov et al. 2002Go; Gudermann et al. 1996Go, 1997Go; Kushmerick et al. 1999Go; LaBelle and Polyak 1998Go; Wellner-Kienitz et al. 2001Go; Xiao 2001Go). Gi/o activates cPLA2, which produces arachidonic acid and lysophospholipids. We have shown that arachidonic acid can bind to and activate BK channels, but lysophospholipids might also contribute to the activation. In cell-attached patches, it is possible that other signaling pathways are also activated (by isoproterenol or AlF4). In fact, it would be surprising if Gs proteins were not activated. Nonetheless, only Gi/o appears to be involved in BK channel activation because pertussis toxin can inhibit isoproterenol-mediated BK stimulation. As suggested by Jelsema and Axelrod (1987)Go, G protein activation can occur via an interaction between an effector and either the {alpha} or {beta}{gamma} subunits after dissociation of the heterotrimeric complex. Because PTX acts by preventing this dissociation, we cannot unequivocally determine whether the activation occurs via an action of the {alpha} or {beta}{gamma} subunits. Along similar lines, both Gi and Go are endogenously expressed in GH3 cells (Gudermann et al. 1996Go; Paulsson et al. 1992Go). Because PTX can inhibit dissociation of both G proteins, we cannot unequivocally identify Gi as the G protein activated by isoproterenol. As suggested by Paulssen et al. (1992)Go, activation of Gi and Go in GH3 cells was agonist specific. However, Gi does appear to be the most likely candidate because it is preferentially activated by isoproterenol (compared with Go) in other cell types (Chung et al. 1999Go; LaBelle and Polyak 1998Go).

In intact cells, if intracellular calcium increases in response to isoproterenol, then this will reinforce the action of cPLA2 to produce an even larger response than Gi/o activation alone. Of course, these alternative pathways cannot contribute to BK activation in excised, inside-out patches (Fig. 8B) where GTP{gamma}S directly activates Gi/o. The effect of GTP{gamma}S cannot be to activate cPLA2 directly because the Gi/o inhibitor, pertussis toxin, completely inhibits the action of GTP{gamma}S. Moreover, Gi/o is not directly activating BK channels because inhibiting cPLA2 expression with antisense oligonucleotides also completely blocks the action of GTP{gamma}S. cPLA2 inhibitors are generally competitive inhibitors that may not produce complete block except at very high inhibitor concentrations; therefore we used antisense oligonucleotides in addition to a pharmacologic inhibitor (AACOCF3) in an effort to minimize any nonspecific effects of the pharmacologic inhibitors on the signal transduction pathways we studied. As anticipated, the results from experiments using either technique were identical.

The smaller response and larger variability in the GTP-{gamma}-S response compared with AlF4 is probably a reflection of the fact that AlF4 was applied to intact cells so that even G proteins outside the patch can contribute to the activation of cPLA2 and production of arachidonic acid that subsequently activates BK channels. We and others have previously reported the activation of BK channels by the direct association of BK-channel proteins with arachidonic acid (and other cis-fatty acids), suggesting that there is a stereo-specific arachidonic acid binding site on the {alpha}-subunit of BK-channels (Clark et al. 1991Go; Denson et al. 2000Go). This implies that association of arachidonic acid with BK channels stabilizes the channel in an open state. When GTP{gamma}S is applied to excised patches, the magnitude of the response will depend on how many Gi/o and cPLA2 proteins are present in the excised patch of membrane. The character of excised patches probably also explains the result of applying GDP{beta}S. GDP{beta}S will inactivate already active G proteins (that are activating BK channels) or inhibit activation of initially inactive G proteins. In an excised patch, there is no reason to expect that G proteins will already be active so application of GDP{beta}S, not surprisingly, will have no effect. Because the application of a pharmacologic inhibitor of c-PLA2 to an excised patch always results in a decrease in Po, we reasoned that there is a close association between c-PLA2 and BK channels in GH3 cells. If the pathway depicted in the cartoon in Fig. 8B is correct, then a significant number of excised patches would contain all of the transduction elements required for BK channel activation by isoproterenol. If this is true, adding isoproterenol to the pipette solution would result in an increase in Po in a significant number of excised patches. Our results showing Po increased in 6/7 patches where isoproterenol had been backfilled in the patch pipette supports this signal transduction pathway.

In summary, we have demonstrated that in addition to the well-documented activation of c-PLA2 by tyrosine phosphorylation or increases in [Cai2+] and subsequent calcium-dependent translocation to the membrane, cPLA2 can be activated by a GPCR, which activates Gi/o. This activation of cPLA2 results in an increased production of arachidonic acid and lysophospholipids and a corresponding increase in the Po of BK channels.


    GRANTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This work was supported by National Science Foundation Grant IBN-0091964 to D. D. Denson and D. C. Eaton and National Institute of Diabetes and Digestive and Kidney Diseases Grant R37DK-37963 to D. C. Eaton.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
The authors gratefully acknowledge B. J. Duke for skillful technical assistance in the plating and maintenance of the cells used in this investigation. The authors also gratefully acknowledge S. Ramosevac for conducting the Western blot analyses.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests and other correspondence: D. D. Denson, Dept. of Anesthesiology, Emory University School of Medicine, 3B-South Emory University Hospital, 1364 Clifton Rd., Atlanta, GA 30322 (E-mail: Don_Denson{at}emoryhealthcare.org)


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Barlow RS, El Mowafy AM, and White RE. H(2)O(2) opens BK(Ca) channels via the PLA(2)-arachidonic acid signaling cascade in coronary artery smooth muscle. Am J Physiol Heart Circ Physiol 279: H475–H483, 2000.[Abstract/Free Full Text]

Chen XJ, Eaton DC, and Jain L. Beta-adrenergic regulation of amiloride-sensitive lung sodium channels. Am J Physiol Lung Cell Mol Physiol 282: L609–L620, 2002.[Abstract/Free Full Text]

Chung S, Soh H, and Uhm D. beta-adrenergic modulation of maxi-K channels in vascular smooth muscle via Gi through a membrane-delimited pathway. Pflugers Arch Eur J Physiol 437: 508–510, 1999.[CrossRef][ISI][Medline]

Clark JD, Lin LL, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, and Knopf JL. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65: 1043–1051, 1991.[CrossRef][ISI][Medline]

Denson DD and Eaton DC. Ketamine inhibition of large conductance Ca(2+)-activated K+ channels is modulated by intracellular Ca2+. Am J Physiol Cell Physiol 267: C1452–C1458, 1994.[Abstract/Free Full Text]

Denson DD, Wang X, Worrell RT, AlKhalili O, and Eaton DC. Cytosolic phospholipase A2 is required for optimal ATP activation of BK channels in GH(3) cells. J Biol Chem 276: 7136–7142, 2001.[Abstract/Free Full Text]

Denson DD, Wang X, Worrell RT, and Eaton DC. Effects of fatty acids on BK channels in GH(3) cells. Am J Physiol Cell Physiol 279: C1211–C1219, 2000.[Abstract/Free Full Text]

Denson DD, Worrell RT, and Eaton DC. A possible role for phospholipase A2 in the action of general anesthetics. Am J Physiol Cell Physiol 270: C636–C644, 1996.[Abstract/Free Full Text]

Denson DD, Worrell RT, Middleton P, and Eaton DC. Ca2+ sensitivity of BK channels in GH3 cells involves cytosolic phospholipase A2. Am J Physiol Cell Physiol 276: C201–C209, 1999.[Abstract/Free Full Text]

Gabriel SM, Milbury CM, Alexander SM, Nathanson JA, and Martin JB. Iso stimulation of GH and cAMP: comparison of beta-adrenergic- to GRF-stimulated GH release and cAMP accumulation in monolayer cultures of anterior pituitary cells in vitro. Neuroendocrinology 50: 170–176, 1989.[ISI][Medline]

Gershengorn MC. Mechanism of thyrotropin releasing hormone stimulation of pituitary hormone secretion. Annu Rev Physiol 48: 515–526, 1986.[CrossRef][ISI][Medline]

Gijón MA, Spencer DM, Kaiser AL, and Leslie CC. Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2. J Cell Biol 145: 1219–1232, 1999.[Abstract/Free Full Text]

Golomb D, Wang KJ, and Rinzel J. Synchronization properties of spindle oscillations in a thalamic reticular nucleus model. J Neurophysiol 72: 1109–1126, 1994.[Abstract/Free Full Text]

Gosmanov AR, Wong JA, and Thomason DB. Duality of G protein-coupled mechanisms for beta-adrenergic activation of NKCC activity in skeletal muscle. Am J Physiol Cell Physiol 283: C1025–C1032, 2002.[Abstract/Free Full Text]

Gudermann T, Kalkbrenner F, and Schultz G. Diversity and selectivity of receptor-G protein interaction. Annu Rev Pharmacol Toxicol 36: 429–459, 1996.[ISI][Medline]

Gudermann T, Schoneberg T, and Schultz G. Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu Rev Neurosci 20: 399–427, 1997.[CrossRef][ISI][Medline]

Guerrero SW and Minneman KP. Coupling efficiencies of beta 1- and beta 2-adrenergic receptors expressed alone or together in transfected GH3 pituitary cells. J Pharmacol Exp Ther 290: 980–988, 1999.[Abstract/Free Full Text]

Hoffman BB.Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists. In: Goodman and Gillman's The Pharmacological Basis of Therapeutics, edited by Hardman JG, Limbird LE, and Gilman AG. New York: McGraw-Hill, 2001, p. 215–268.

Jelsema CL and Axelrod J. Stimulation of phospholipase A2 activity in bovine rod outer segments by the beta gamma subunits of transducin and its inhibition by the alpha subunit. Proc Natl Acad Sci USA 84: 3623–3627, 1987.[Abstract/Free Full Text]

Katada T, Bokoch GM, Smigel MD, Ui M, and Gilman AG. The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Subunit dissociation and the inhibition of adenylate cyclase in S49 lymphoma cyc- and wild type membranes. J Biol Chem 259: 3586–3595, 1984.[Abstract/Free Full Text]

Kruger H, Carr S, Brennand JC, and McLean JS. Activation of phospholipase A2 by the human endothelin receptor in Chinese hamster ovary cells involves Gi protein-mediated calcium influx. Biochem Biophys Res Commun 217: 52–58, 1995.[CrossRef][ISI][Medline]

Kushmerick C, Romano-Silva MA, Gomez MV, and Prado MA. Muscarinic regulation of Ca2+ oscillation frequency in GH3 cells. Brain Res 851: 39–45, 1999.[Medline]

LaBelle EF and Polyak E. Norepinephrine stimulates arachidonic acid release from vascular smooth muscle via activation of cPLA2. Am J Physiol Cell Physiol 274: C1129–C1137, 1998.[Abstract/Free Full Text]

Leslie CC. Properties and regulation of cytosolic phospholipase A2. J Biol Chem 272: 16709–16712, 1997.[Free Full Text]

Liu J, Takano T, Papillon J, Khadir A, and Cybulsky AV. Cytosolic phospholipase A2-alpha associates with plasma membrane, endoplasmic reticulum and nuclear membrane in glomerular epithelial cells. Biochem J 353: 79–90, 2001.